Literature DB >> 16208176

Reference ranges for 51Cr-EDTA measurements of glomerular filtration rate in children.

Glen M Blake1, Natasha Gardiner, Gopinath Gnanasegaran, Sabina Dizdarevic.   

Abstract

BACKGROUND: 51Cr-Ethylenediaminetetraacetic acid (51Cr-EDTA) is widely used to measure the glomerular filtration rate (GFR) in children and adults. AIM: To produce paediatric reference data for use with the British Nuclear Medicine Society (BNMS) GFR guidelines.
METHODS: This was a retrospective study of children and adolescents, aged 0-17 years, undergoing combined 99mTc-dimercaptosuccinic acid (99mTc-DMSA) scintigraphy and GFR examination. GFR was evaluated from Cr-EDTA plasma clearance using blood samples taken at 2, 3 and 4 h according to the methods set out in the BNMS GFR guidelines. 99mTc-DMSA images were reviewed to identify children with normal scans.
RESULTS: Of the 45 children having a combined 99mTc-DMSA and GFR investigation, 27 (12 females, 15 males) had a normal scan result. The mean GFR (standard deviation) in the 24 subjects aged 2-17 years was 109.5 (16.8) ml . min(-1) . (1.73 m2)(-1). This compared with a predicted figure of 107.0 (17.0) ml . min(-1) . (1.73 m2)(-1) when the paediatric reference range published by Piepsz et al. was adjusted to be consistent with the BNMS GFR guidelines. When the GFR results in the present study were calculated according to the single-sample and two-sample methods used by Piepsz et al., there was close agreement with the results obtained in the latter study [116.7 (24.2) vs. 114.7 (25.8) ml . min(-1) . (1.73 m2)(-1)]. Children with abnormal 99mTc-DMSA scans had significantly lower GFR than those with normal scans (P=0.003).
CONCLUSION: There is a consistent difference between the GFR results in children with normal 99mTc-DMSA scans obtained in the present study and the unadjusted results of Piepsz et al. that can be explained by the different methods of calculating GFR in the two studies. Given the larger number of children in the latter study, it is proposed that centres evaluating GFR according to the BNMS method should adopt the Piepsz et al. reference range adjusted for consistency with the BNMS guidelines. This gives a mean GFR (SD) in children of 2 years and over of 107 (17) ml . min(-1) . (1.73 m2)(-1).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208176     DOI: 10.1097/01.mnm.0000179294.16339.4a

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.

Authors:  Wei Zhao; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

2.  Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2).

Authors:  Hans Pottel; Liesbeth Hoste; Pierre Delanaye
Journal:  Pediatr Nephrol       Date:  2014-11-19       Impact factor: 3.714

3.  Glomerular hyperfiltration in children with cancer: prevalence and a hypothesis.

Authors:  Neha S Kwatra; Holly J Meany; Sunil J Ghelani; David Zahavi; Nayan Pandya; Massoud Majd
Journal:  Pediatr Radiol       Date:  2016-11-03

4.  Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children.

Authors:  A Piepsz; M Tondeur; H Ham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-25       Impact factor: 10.057

5.  Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment.

Authors:  Puriya Daniel Yazdanfard; Christoffer Valdorff Madsen; Lars Holme Nielsen; Åse Krogh Rasmussen; Jørgen Holm Petersen; Alka Seth; Søren Schwartz Sørensen; Lars Køber; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2019-12-06       Impact factor: 3.240

6.  First Report on the Percentiles of the Glomerular Filtration Rate in Iranian Children Using the 2009 Schwartz Equations.

Authors:  Peyman Roomizadeh; Alaleh Gheissari; Roya Kelishadi; Farhad Mahmoudi; Amin Abedini
Journal:  Iran J Med Sci       Date:  2018-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.